Peringkat dalam Saham
#11593
CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical... CinCor Pharma, Inc. is an emerging biopharmaceutical firm in the clinical development phase, dedicated to pioneering therapeutic solutions for cardiovascular and renal conditions. At the core of its pipeline is CIN-107, an investigational compound currently undergoing Phase II clinical trials for indications such as hypertension, primary aldosteronism, and various other cardio-renal disorders. Additionally, CIN-107 is in Phase I clinical evaluation for its potential in treating chronic kidney diseases. The company holds a significant licensing agreement with F. Hoffman-La Roche Ltd. and Hoffmann-La Roche Inc. Established in 2018, CinCor Pharma, Inc. maintains its principal operations in Boston, Massachusetts.
Harga Saham
$29.06
Terakhir disinkronkan: 2023-02-23
Kapitalisasi Pasar
$682.73M
Perubahan (1 hari)
-0.48%
Perubahan (1 tahun)
0.00%
Perdagangan CinCor Pharma, Inc. (CINC)
Harga CINC dengan kapitalisasi pasar B
Kapitalisasi pasar dari CinCor Pharma, Inc.(CINC)
Kapitalisasi Pasar: $682.73M
Per August 2026, CinCor Pharma, Inc. memiliki kapitalisasi pasar sebesar $682.73M. Ini menjadikan CinCor Pharma, Inc. sebagai perusahaan 11593rd paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar CinCor Pharma, Inc. dari 2022 hingga 2026
CINC dibandingkan dengan 5 teratas stocks paling populer
| Harga CINC |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.264T
|
+770,907.55%
|
|
|
|
|
$4.701T
|
+688,503.78%
|
|
|
|
|
$4.177T
|
+611,738.24%
|
|
|
|
|
$3.817T
|
+559,041.15%
|
|
|
|
|
$2.866T
|
+419,737.17%
|
